OOIR: Observatory of International Research

Papers

(The H4-Index of Cancer and Metastasis Reviews is 31. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Editorial Expression of Concern: Targeting microRNAs as a promising anti-cancer therapeutic strategy against traffic-related air pollution-mediated lung cancer	159
Immunotherapy for leptomeningeal disease from solid tumors: current clinical outcomes and future opportunities	158
New insights for gynecological cancer therapies: from molecular mechanisms and clinical evidence to future directions	127
Of vascular defense, hemostasis, cancer, and platelet biology: an evolutionary perspective	94
The role of microbiome in pancreatic cancer	85
The impact of tumor microenvironment: unraveling the role of physical cues in breast cancer progression	79
The functions and modifications of tRNA-derived small RNAs in cancer biology	70
CAR T-cell therapy for B-cell lymphomas: outcomes and resistance mechanisms	66
Regulation of dormancy during tumor dissemination: the role of the ECM	61
Clonal tracking in cancer and metastasis	59
Obesity and cancer	57
Chemokines orchestrate tumor cells and the microenvironment to achieve metastatic heterogeneity	51
Immunotherapy for triple negative breast cancer: the end of the beginning or the beginning of the end?	46
Progression and metastasis of small cell lung carcinoma: the role of the PI3K/Akt/mTOR pathway and metabolic alterations	46
The effect of GLP-1R agonists on the medical triad of obesity, diabetes, and cancer	46
CAR T-cell therapy to treat multiple myeloma: current state and future directions	45
Targeting lipid metabolism in cancer: neuroblastoma	45
Natural killer cells in neuroblastoma: immunological insights and therapeutic perspectives	42
The paradoxical role of inositol in cancer: a consequence of the metabolic state of a tumor	42
KISS1 metastasis suppressor in tumor dormancy: a potential therapeutic target for metastatic cancers?	40
Cell-cell interactions mediating primary and metastatic breast cancer dormancy	40
TRIM-endous functional network of tripartite motif 29 (TRIM29) in cancer progression and beyond	39
Correction to: Cutting the edge between cancerogenesis and organogenesis of the pancreatic endocrine lineage allocation—comprehensive review of the genes Synaptotagmin 13 and 533041C22 Rik in epitheli	35
Healthcare disparities, screening, and molecular testing in the changing landscape of non–small cell lung cancer in the United States: a review	35
p73 isoforms meet evolution of metastasis	34

A multidisciplinary perspective on the complex interactions between sleep, circadian, and metabolic disruption in cancer patients	34
Targeting microRNAs as a promising anti-cancer therapeutic strategy against traffic-related air pollution-mediated lung cancer	33
Preface	33
Biography—Mathieu Boissan, Pharm.D., Ph.D	33
Neuropeptide Y in cancer—biological functions and potential clinical implications	31
Biographies	31
LGR5: An emerging therapeutic target for cancer metastasis and chemotherapy resistance	31